作者：
Carr, Daniel F. [1]
;
Ayehunie, Seyoum [2]
;
Davies, Andrea [3]
;
Duckworth, Carrie A. [4]
;
French, Stephanie [5]
;
Hall, Neil [6]
;
Hussain, Syed [7]
;
Mellor, Howard R. [8]
;
Norris, Alan [9]
;
Park, B. Kevin [10]
;
Penrose, Alexander [11]
;
Pritchard, D. Mark [12]
;
Probert, Chris S. [13]
;
Ramaiah, Shashi ;
Sadler, Claire ;
Schmitt, Michael ;
Shaw, Alison ;
Sidaway, James E. ;
Vries, Robert G. ;
Wagoner, Matthew ;
Pirmohamed, Munir
作者单位：
Vertex Pharmaceut Europe, Abingdon, Oxon, England
[1]
Pfizer Inc, Cambridge, MA USA
[2]
Merck KGaA, Darmstadt, Germany
[3]
MatTek Corp, Ashland, MA USA
[4]
Hubrecht Organoid Technol, Utrecht, Netherlands
[5]
Univ Liverpool, Inst Translat Med, Dept Clin & Mol Pharmacol, MRC,Ctr Drug Safety Sci, Liverpool
[6]
ApconiX, Alderley Edge, Cheshire, England
[7]
Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3GE, Merseyside
[8]
Univ Liverpool, Inst Integrat Biol, Dept Comparat & Funct Genom, Liverpool L69 7ZB, Merseyside
[9]
Med & Healthcare Prod Regulatory Agcy, London, England
[10]
Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool L69 3GA, Merseyside, England
[11]
AstraZeneca, Innovat Med & Early Dev, Drug Safety & Metab, Waltham, MA USA
[12]
Phenotox Ltd, Bollington, Cheshire, England
[13]
发布时间
2017-11-22
换一批
